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Abstract 
Objective: To identify the predictive factors for the appearance of oral mucositis (OM) 
in pediatric oncology patients based on their motor alterations. Material and Methods: 
This study was an observational, cross-sectional study with 2-19-year-old patients 
undergoing treatment at the pediatric oncology outpatient service of the Napoleão 
Laureano Hospital in João Pessoa, Brazil. The convenience sample consisted of 42 
patients aged 2 to 19 years with a first diagnosis of cancer and under treatment. The 
instruments used were a questionnaire with sociodemographic questions - the modified 
Oral Assessment Guide (OAG) - and some categories of the International Classification 
of Functioning Disability and Health (CIF), applied by a calibrated examiner 
(Kappa>0.65). The data were organized in Excel spreadsheet and analyzed descriptively 
and inferentially using logistic regression (α=5%). Results: Most patients were female 
(52.4%, n=22), mean age of 11.6 years, median 12.0 years, self-declared as non-white 
(61.9%, n=26), non-white (66.7%, n=28), family monthly income of up to 2 Brazilian 
minimum wages (88.1%, n = 37). Most patients presented hematologic neoplasia (54.8%, 
n=23) with acute lymphoid leukemia (36.6%; n=15) and most of them were subjected to 
chemotherapy (45.2%; n = 19). OAG identified oral mucositis in a few cases (23.8%, 
n=10). Logistic regression and odds ratio showed that individuals with moderate and 
mild difficulty in changing basic body position had, respectively, 19.7 and 30.8 times 
more chances of developing oral mucositis. In patients with severe motor impairment, 
this risk is 17.3 times greater and those with mild difficulty in taking care of the bodily 
parts had an increase of 33.4 times the risk for oral mucositis. Conclusion: The deficit in 
motor activities increased the chances of developing oral mucositis. 
 
Keywords: Child; Neoplasms; Stomatitis; Motor Activity; Logistic Models.
Pesq Bras Odontoped Clin Integr 2017, 17(1):e3836 
 
2 
Introduction 
In the last 40 years, the treatment for childhood cancer has shown continuous improvement 
and these advances have been attributed to a more effective use of anti-leukemic agents, the 
intensification of treatment when required, the identification of prognostic factors for risk 
stratification, and the improvements in supportive care [1]. The treatment options are surgery, 
chemotherapy, radiotherapy, bone marrow transplantation and immunotherapy, alone or in 
combination, depending on the indication for each case [2,3]. In the same way as cancer cells, 
normal cells with a high mitotic activity, such as cells from the oral mucosa, gastrointestinal mucosa, 
bone marrow and skin, are also susceptible to the action of cancer treatments [4]. 
The oral cavity suffers a great impact of the anticancer treatment, the main side effects being 
mucositis, xerostomia, candidiasis, hemorrhage, radiation caries, dysgeusia, neurotoxicity, 
osteoradionecrosis, trismus and dentinal hypersensitivity, apart from fungal, herpetic and bacterial 
infections. It is known that mucositis, xerostomia, hemorrhage and infections occur three times more 
often in children than in adults [2,5-7]. Other complications related to the anticancer treatment and 
its oral alterations are discomfort and pain, which may result in nutritional deficit, impaired immune 
response and a longer hospitalization time, increasing the risk of death [8]. 
Other deleterious effects of the antineoplastic treatment are the motor alterations and 
impairments, such as reduction of active and passive joint amplitude, along with loss and/or decrease 
of muscle strength, decrease of motor skills, limitation of functional mobility and loss of physical 
conditioning, which may lead to reduction in cardiorespiratory capacity, weight gain and growth 
hormone alterations. These changes altogether affect the functional status and the quality of life of 
oncology patients [9,10]. 
Advance of research in this perspective is necessary to understand the patient’s health 
condition during the anticancer treatment, as well as the most prevalent alterations that arise with 
the start of therapy. New studies in this field may guide multidisciplinary practices to prevent or 
minimize secondary complications, contributing to a more efficient health care and a better quality of 
life for the patients. 
Given the above, the objective of this study was to identify the predictive factors for the 
onset of oral mucositis in pediatric oncology patients with motor impairments. 
 
Material and Methods 
Study Design and Sample 
This was an observational, cross-sectional and analytical study with follow-up of a 
population with cancer undergoing treatment at the pediatric oncology outpatient service of the 
Napoleão Laureano Hospital in the city of João Pessoa, capital of the state of Paraiba, located in the 
northeastern region of Brazil, considered the easternmost part of the Americas and the country. The 
study was developed from April to September 2017. 
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Population 
The study population consisted of pediatric oncology patients treated at the pediatric 
oncology outpatient service of the Napoleão Laureano Hospital (HNL) and their parents/caregivers. 
Convenience sampling and convenient accessibility were used for selecting a sample of 42 children 
and adolescents aged 2 to 19 years diagnosed with some form of neoplasias and admitted at the 
Napoleão Laureano Hospital pediatric oncology outpatient service. 
All patients aged between 2 and 19 years undergoing anticancer treatment (chemotherapy, 
radiotherapy and/or surgery) and with a primary diagnosis of malignant neoplasia were considered 
eligible for this study. Patients with chronic diseases and compromised health status were excluded 
from the study. 
 
Data Collection 
Before data collection, a pilot study was carried out to test the instruments, materials and 
method proposed for the study. Five individuals selected by convenience who fulfilled the inclusion 
criteria were subjected to an interview. Although overall positive, the results showed that some 
adaptations should be done in the data collection instrument, such as the use of synonyms and a 
simpler language, without changing the meaning of the categories related to the International 
Classification of Functioning, Disability and Health (ICF), to improve the understanding of younger 
participants and avoid misinterpretation. 
The instrument used for this study presented three sections: the first contains questions 
regarding socioeconomic and clinical issues; the second contains questions from the modified Oral 
Assessment Guide (OAG) [11]; and the third section contains questions from ICF’s activity and 
participation domains. Data collection was performed by a previously trained and calibrated 
examiner (Kappa>0.65).  
The following variables were considered for the study: presence of mucositis, sex, age, skin 
color, education, family monthly income, type of neoplasias (hematological or solid tumors), type of 
treatment, changing basic body position (d410), maintaining a body position (d415), transferring 
oneself (d420), lifting and carrying objects (d430), moving objects with lower extremities (d435), fine 
hand use (d440), hand and arm use (d445), walking (d450), moving around (d455), moving around in 
different locations (d460), moving around using equipment (d465), using transportation (car, bus, 
train, plane, etc). (d470), driving (riding bicycle and motorbike, driving car, etc.) (d475), riding 
animals for transportation (d480), hygiene (bathing, drying, washing hands, etc.) (d510), caring for 
body parts (brushing teeth, shaving, etc.) (d520), personal hygiene related to the processes of 
excretion (d530), dressing (d540), eating (d550), drinking (d560), Looking after one's health (d570). 
The questionnaire was applied to the participants at HNL’s wards and dental office, which had 
suitable conditions to perform this phase of data collection. This phase of the study lasted 20 to 30 
min on average, including the examiner reading the questions and examining the patient’s oral 
cavity, as required by the OAG. In cases where there was a cognitive and/or speech impairment, the 
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questions were made to the parent/caregiver or proxy informant. Data collection required use of the 
following materials: hospital bed and/or reclining chair, clinical ladder, white coat, gloves, disposable 
mask and cap and hand lights or reflectors. 
 
Statistical Analysis 
The data were first inserted in Excel spreadsheets and then transferred to the R software 
(The R Project for Statistical Computing, version 3.3.1). Data were analyzed using descriptive and 
inferential statistical methods. Descriptive analysis used frequencies, means and standard deviations.  
For inferential statistics logistic regression was used to identify the variables associated with 
the onset of mucositis in the patients and thus aid in the decision-making process to minimize its 
occurrence. Each independent variable was analyzed for the test of predictive factors by univariate 
regression analysis, adopting a 0.30 statistical significance level for selection of the variables to be 
used for the adjustment of the multiple model. Adjustment of the final model was performed using 
the backward method with a significance level of 0.05. Then it was evaluated the model adjustment, 
sensitivity, specificity and predictive values, as well as the model explanatory power by analyzing the 
area under the receiver operating characteristic (ROC) curve. 
 
Ethical Aspects 
The research protocol was approved by the Research Ethics Committee (CEP) of the Federal 
University of Paraíba (Protocol No. CAAE 63759516.0.0000.5188) and the study was conducted in 
compliance with the Brazilian National Health Council (CNS) Resolution 466/12, which establishes 
the ethical standards for conducting research involving human beings. 
 
Results 
Forty-two children and adolescents were evaluated, 52.4% (n=22) of them being female and 
the mean age was 11.6 years (Table 1). 
 
Table 1. Frequency distribution of the characteristics of 2-19-year-old children and adolescents treated 
at the Napoleão Laureano Hospital. 
Variables n % 
Sex 
Female 22 52.4% 
Male 20 47.6% 
    
Age 
<13 years  22 52.4% 
>13 years  20 47.6% 
    
Skin Color 
White 16 38.1% 
Non-white 26 61.9% 
    
Education 
No education 4 9.5% 
Kindergarten 5 11.9% 
Elementary school 28 66.7% 
Secondary school 5 11.9% 
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Family Income 
Monthly 
Up to 2 minimum wage* 37 88.1% 
2 to 6 minimum wage*. 5 11.9% 
    
Cancer Type 
Hematological type 23 54.8% 
Solid tumor 19 45.2% 
    
Treatment  
Chemotherapy  19 45.2% 
Surgery 3 7.2% 
Chemotherapy + Radiotherapy 4 9.5% 
Chemotherapy + Surgery 11 26.2% 
Chemotherapy + Radiotherapy + Surgery 5 11.9% 
    
Mucositis 
Present 10 23.8% 
Absent  32 76.2% 
*Brazilian minimum wage: $300.99; Dollar course April 2017: R$3.1130 
 
Regarding the self-reported skin color, 61.9% (n=26) were non-whites and 38.1% (n=16) 
were whites. Regarding education, 66.7% (n=28) were attending elementary school and 9.5% (n=4) 
were out of school. The family monthly income of most participants (88.1%; n=37) was up to 2 
Brazilian minimum wages. 
Most children and adolescents (54.8%; n=23) had hematologic neoplasias, among which 
36.6% (n=15) had a diagnosis of acute lymphoid leukemia. Regarding the solid tumors (45.2%; 
n=19), the highest prevalence was osteosarcoma (12.2%; n=5). Regarding the antineoplastic 
treatment, chemotherapy was the most frequently mentioned (45.2%; n=19) followed by the 
combination between surgery and chemotherapy 26.2% (n=11). 
From the data collected with the OAG, it was found that 23.8% (n=10) of the patients 
presented mucositis. The study used the logistic regression model (LRM) to identify independent 
variables associated with the presence of mucositis that could compose the final model.  
First, each independent variable was submitted to the chi-square test and the variables that 
presented statistical significance (p<0.3) were included in the final model (Table 2). It is important to 
note that due to the variety of subcategories of some variables, such as the skin color, education, 
walking, among others, they had to be grouped for the chi-square test in order to identify whether 
they were indeed significant for the model. Without this clustering, variables relevant to the model 
could be excluded. 
 
Table 2. Explicative variables and their p values relative to the endpoint (p<0.3). 
Variables Significance 
Education  0.263* 
Changing basic body position (performance) 0.111* 
Walking (performance)  0.035* 
Moving around (performance) 0.219* 
Maintaining a body position (capacity)  0.005* 
Transferring oneself (capacity)  0.035* 
Lifting and carrying objects (capacity) 0.035* 
Walking (capacity) 0.207* 
Moving around in different locations (capacity) 0.064* 
Caring for body parts (brushing teeth, shaving, etc.) (capacity)  0.018* 
*p<0.3. 
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The Backward method was then used for selection of variables in the logistic regression. 
This procedure removes the variable with highest p value, one at a time, and is repeated until only 
significant variables are left to obtain a model that can explain the event of interest. A 5% 
significance level was set for variable selection (α=0.05) (Table 3). 
 
Table 3. Significant variables in the adjusted logistic regression model. 
Variables Parameter 
Estimation 
Standard 
Error  
p value OR IC95%[OR] 
Intercept -3.421 1.039 0.000   
Changing basic body position (performance – 
mild difficulty) 
3.427 1.745 0.049 30.78415 27.3639 - 34.2043 
Maintaining a body position (capacity – 
moderate difficulty) 
2.979 1.375 0.030 19.66814 16.9731 - 22.3631 
Moving around (capacity – severe difficulty) 2.853 1.485 0.054 17.33972 14.4291 - 20.2503 
Caring for body parts (brushing teeth, 
shaving, etc.) (capacity – mild difficulty) 
3.510 1.369 0,010 33.44827 30.7656 - 36.123 
*Significant p-value <0.05 
 
The final model selected 4 of the 51 initial variables that presented statistical significance 
(p<0.05): changing basic body position (performance); maintaining a body position (capacity); 
transferring oneself (capacity) and caring for body parts (brushing teeth, shaving, etc.) (capacity). It 
is worth noting that the variable "transferring oneself " remained in the model because it presented a 
p value close to the significance level and because it is an important variable to justify the final 
model. 
After defining the model, its validity must be verified. Therefore, the function deviation or 
deviance measures the discrepancy between the saturated model (best model) and the study model 
[12]. The deviance statistics of the adjusted logistic regression model (24.8913) is lower than the 
reference chi-square value (52.19232), considering the adequate model. 
Adjustment quality of the obtained model can also be checked using the ROC curve, which is 
a graph of sensitivity versus false positive rate. The accuracy of the diagnostic test is proportional to 
the area under the curve, i.e., the larger the area, the more accurate the test. Thus, a decision rule 
based on the "cutoff point" is adopted, which summarizes the probability in a dichotomic response 
[12]. Individuals with an estimated probability lower and higher than the cut-off point are classified 
as patients with absence and presence of mucositis, respectively. According to the ROC curve, it was 
observed a cutoff of 0.032, sensitivity of 100.0%, specificity of 81.2% and area under the curve equal 
to 0.914 or 91.4% (Figure 1). 
Among the variables presented in this model, there are those that represent risk factors to 
the occurrence of mucositis: changing basic body position, maintaining a body position, transferring 
oneself (capacity) and caring for body parts. Then, the odds ratio of the final logistic regression 
model variables was calculated to assess the effect of each variable on the likelihood of occurrence of 
mucositis (Table 4). 
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Figure 1.  Graph of the ROC curve, specificity and sensitivity. 
 
Table 4. Odds ratio (OR) estimations (p<0.05). 
Variables OR  IC 95% [OR] 
Changing basic body position (performance – mild difficulty) 30.78415 27.3639 - 34.2043 
Maintaining a body position (capacity – moderate difficulty) 19.66814 1.9731 - 22.3631 
Moving around (capacity – severe difficulty) 17.33972 14.4291 - 20.2503 
Caring for body parts (brushing teeth, shaving, etc.) (tooth 
brushing, shaving, etc.) (capacity – mild difficulty) 
33.44827 30.7656 - 36.123 
 
According to the found OR values, individuals who have mild difficulty in changing basic 
body position, even with help, are 30.8 times more likely to develop mucositis while individuals with 
a moderate difficulty in maintaining a body position have 19.7 times greater likelihood. Individuals 
with severe difficulty in transferring themselves are 17.3 times more likely to develop mucositis, and 
those who have mild difficulty in caring for their body parts are 33.4 times more likely to have this 
oral condition. 
 
Discussion 
The anticancer treatment for children and adolescents has an adverse impact on their quality 
of life, as the therapy may cause complications that affect their routine activities, self-concepts and 
interpersonal and social relationships [10,13-15]. Based on this, the aim of this study was to identify 
predictive factors for the onset of oral mucositis in pediatric oncology patients with motor 
impairments. The number of participants (n=42) agrees with other studies that had similar 
populations [16-18]. This small sample size can be explained by the low incidence of childhood 
cancer compared with cancer in adults, accounting to only 1-3% of all malignant tumors worldwide 
[1]. In the same way as observed in other national and international studies [10,18,19], children at 
early ages were the most frequently affected. 
The results of the present study showed a predominance of cases in females, as observed by 
other authors [18,20,21], differently from most similar studies that indicate a higher incidence of 
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cancer in males [2,22-24]. This finding could be explained by a combination of factors: the 
distribution of the Brazilian female population (51%), the new cancer cases in females estimated for 
the 2016-2017 biennium [1], and the fact that the state of Paraíba particularly has a higher incidence 
of cancer in females (51.6%) according to IBGE 2010 data. 
The non-white skin color was the most frequently referred, which agrees with another Brazilian 
study [25] and may be a result of the significant miscegenation of our population. 
In agreement with the literature, there was a predominance of hematological malignancies in 
the present study, and ALL was the most common type [2,26]. It is noteworthy that ALL has its 
peak incidence between 2 and 5 years, with a remission rate of approximately 80% [27]. Leukemias 
are the most common malignancies in childhood, accounting for 25-35% of all tumors in patients 
below 14 years of age [1].  
Chemotherapy is the most widely used anticancer therapy. Accordingly, it was the most 
frequent treatment reported in the present study, alone or in combination with surgery or other 
therapies, as reported in other studies [17,26]. Chemotherapy is used in approximately 70% of 
cancer patients, as it has the highest remission rate for many tumors and increases the most the 
survival rate of patients [26]. 
The various types of antineoplastic treatment may cause adverse effects to the oral cavity. 
Oral mucositis is one of the main oral complications [2,6,13] affecting 20-40% of individuals 
undergoing chemotherapy, 60-85% of those undergoing hematopoietic stem cells transplantation 
(HSCT) and nearly 100% of those undergoing head and neck radiotherapy [28]. 
In the present study, the pediatric oncology patients had oral mucositis prevalence of 23.8%, 
similar to other studies [17,24] but lower than most national and international studies [18,23]. This 
fact could be attributed to the sample size, diversity of treatment modalities and individual patient 
response. Oral mucositis is a common and clinically relevant side effect of chemotherapy and 
radiotherapy, and may affect any part of the gastrointestinal tract. The onset of oral mucositis 
usually occurs between the 3rd and 4th day after the start of treatment, worsening between the 7th 
and 14th days, with clinical manifestation varying from mucosa irritation to ulceration [28]. 
The results of this study showed that motor impairment favors the occurrence of oral 
mucositis, identifying a statistically significant association between the development of this 
comorbidity and mild difficulty in changing basic body position, even with help. There was also an 
association between mild difficulty in caring for bod parts and oral mucositis. It was observed that 
children and adolescent with cancer realize the limitations imposed by the disease, but parents and 
professionals’ care and warning contribute to restrain even more the autonomy of their activities 
[29]. However, the development of oral mucositis may be sometimes associated with preexisting 
caries and periodontal diseases that aggravate due to poor hygiene, creating favorable conditions to 
the onset of oral mucositis [23,24,26]. A feasible hypothesis is that, during the course of treatment, 
these remain have long stays in a hospital bed due to cancer side effects, mobility restriction and to 
medical devices [10], which makes oral hygiene difficult and increases the likelihood of developing 
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oral mucositis. Adequate oral hygiene can both prevent and accelerate the healing of oral mucositis 
[28,30]. 
The outcomes of this study also showed that individuals with severe difficulty in 
transporting oneself were more susceptible to developing oral mucositis. Studies indicate that 
children and adolescents with cancer have greater inactivity, reduced muscle strength, 
musculoskeletal morbidities, fatigue and neurocognitive impairment, and most likely have a 
sedentary lifestyle, being at higher risk of obesity, growth hormone deficiency and decrease of bone 
density [10,16]. It is also important to understand that the development of oral mucositis is related 
not only to the type of anticancer treatment, but also to the patient’s oral health status and immune 
markers, such as inflammatory mediators and immunosuppressors [30]. So, it can be assumed that 
the motor alterations caused by cancer weaken the patients, decreasing their immunity and 
increasing the risk of infection/sepsis and the chances of development of oral mucositis. 
The results of this study show that this group of patients requires special care and innovative 
strategies that can improve not only their physical capacity, but also their systemic condition, which 
reflect on their oral health and quality of life. 
This study has limitations. The first one is its cross-sectional design, which analyzes the 
variables of interest in a single moment in time, biasing the establishment of cause-effect 
relationships since the changes in the patients’ health status during the course of treatment cannot 
be considered. Another limitation is the sample size, which was small for the number of studied 
variables, a fact that could influence the association among them. However, even with these 
limitations, this study contributes to support the decision-making process of health professionals 
regarding the treatment of pediatric oncology patients by widening the perspectives for more 
efficient and specific interventions that consider the motor impairments of these children. Further 
research is required to stimulate new insights on this subject in order to address issues not 
contemplated in the present study, thus increasing knowledge and proposing interventions to 
minimize the harmful effects of antineoplastic treatments. 
 
Conclusion 
Motor alterations related to dislodgment and self-care increased the chance of children and 
adolescents with cancer to develop oral mucositis, revealing not only that oral care is important to 
prevent this condition, but also that attention to the motor deficit may influence positively the oral 
health. 
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